Clinical trial registry record

Obesity, Inflammation and Aging: Effects of Physical Exercise and Omega-3 Fatty Acids.

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated November 30, 2020.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT03300388
Last registry update
November 30, 2020
Status
Completed
Phase
Phase not reported
Sponsor
Clinica Universidad de Navarra, Universidad de Navarra
Enrollment
85
Countries
Spain
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · BASIC SCIENCE · DOUBLE
Evidence population
Human clinical study registration
Participants
85
Population
FEMALE · 55 Years to 70 Years
Duration
2017-08-21 to 2019-06-13
Intervention
Omega-3 (DHA-rich dietary supplement); Placebo (olive oil); Resistance training
Comparator
Control
Outcomes measured
Fat mass reduction — Week 0 (baseline); Fat mass reduction — Week 16 (end of intervention); Evolution of fat mass reduction — Week 0 (baseline); Evolution of fat mass reduction — Week 2; Evolution of fat mass reduction — Week 4; Evolution of fat mass reduction — Week 6; Evolution of fat mass reduction — Week 8; Evolution of fat mass reduction — Week 10; Evolution of fat mass reduction — Week 12; Evolution of fat mass reduction — Week 14; Evolution of fat mass reduction — Week 16 (end of intervention); Weight loss — Week 0 (baseline); Weight loss — Week 2; Weight loss — Week 4; Weight loss — Week 6; Weight loss — Week 8; Weight loss — Week 10; Weight loss — Week 12; Weight loss — Week 14; Weight loss — Week 16 (end of intervention)
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Exercise · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Title supplies ageing or longevity context.
  • Omega-3 fatty acids · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Title supplies ageing or longevity context.

Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.